Clinical Trials Browser

Interventional × Lung Neoplasms × Immunologic Factors × Clear all

NCT02976740 2016-11-29

SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

Phase 2 Unknown

Lung Neoplasms